Zurich, 20.12.2024 – SkyCell, a global leader in safe, secure, and sustainable pharma supply chain solutions, is excited to announce a strategic partnership with Validaide, the Netherlands-based digital platform for pharma lane risk management and collaboration. With this partnership, SkyCell has made a multimillion investment to become a major shareholder in Validaide, reaffirming its commitment to innovation and sustainability in the pharma supply chain. 

This investment strengthens Validaide’s position as a leader in lane risk assessment while ensuring it remains an independent and trusted platform serving over 1,600 companies globally. It also unlocks additional resources to accelerate Validaide’s growth and deliver enhanced features and value for its growing user base. 

Validaide: Empowering Industry Collaboration

Validaide will continue to operate as a neutral platform, ensuring it remains a trusted partner for all industry stakeholders, including pharmaceutical companies, freight forwarders, airlines, and packaging providers. This neutrality ensures that all parties can confidently rely on Validaide’s scientifically grounded risk assessments and collaboration tools. 

“Validaide’s independence is fundamental to its role as a platform that benefits the entire industry,” said Richard Ettl, CEO of SkyCell. “This partnership enhances Validaide’s capabilities while safeguarding its neutrality, ensuring it remains the go-to solution for safer, more efficient supply chains.” 

“Our commitment to neutrality has been a cornerstone of the company’s growth and remains a guiding principle for the future.” added Eelco de Jong, co-founder and managing director of Validaide.

Leadership in Lane Risk Assessment

Validaide is a recognized leader in lane risk assessment, trusted by over 1,600 companies worldwide. At the heart of Validaide’s platform is the Pharma Index – a trusted benchmark that reflects the overall quality of healthcare shipments. Derived from an average of key performance metrics, it provides actionable insights to help stakeholders reduce risks and improve efficiency in supply chain decisions. 

“Validaide’s platform brings unparalleled transparency to the pharma supply chain and fosters collaboration among stakeholders,” added Nico Ros, CTO of SkyCell. “We look forward to expanding its reach so even more companies can benefit from its innovative solutions.” 

Accelerating Innovation with New Resources

SkyCell’s investment provides Validaide with the resources to expand its tech team and accelerate the delivery of new features. Planned enhancements include: 

• Faster lane approvals to reduce delays. 

• Advanced risk modeling tools for greater precision. 

• Enhanced regulatory compliance features to streamline operations. 

• Integration of emissions reporting to align sustainability goals. 

These innovations aim to deliver greater value to all users, simplifying processes and reducing risks across the pharma supply chain. Validaide’s expanded capabilities will ensure it continues to provide industry-leading solutions in lane risk assessment and collaboration. 

A Shared Vision for the Future

Together, SkyCell and Validaide share a commitment to creating a safer, more sustainable, and efficient pharma supply chain. This collaboration combines Validaide’s qualitative data on logistics supplier capabilities with SkyCell’s quantitative temperature data, ensuring Validaide’s neutrality while providing stakeholders with a comprehensive toolset for optimizing routing, improving compliance, and achieving sustainability goals. 

“Our shared vision is to drive innovation and sustainability while improving operational efficiency across the supply chain,” said Richard Ettl. “This partnership ensures we can meet the evolving needs of the industry together.” 

About Validaide
Validaide is a leading software provider specializing in lane risk assessment for the freight forwarding and pharmaceutical industries. Based in the Netherlands, Validaide’s platform fosters collaboration and transparency among industry stakeholders to create safer, more efficient supply chains.